[en] Prostatic cancer (PC) became the first diagnosed cancer in western men and is the second leading cause of cancer death in men. Wide utilisation of serum PSA and free PSA measurements, identifies patients requiring transrectalultrasonography (TRUS) and TRUS guided biopsies. Most prostatic cancers diagnosed today are locally limited and may be treated by radical surgery or radiotherapy. In case of disseminated disease, hormonal manipulations remain the treatment of choice. In that field, many new drugs have been designed to allow medical castration with less complications, especially regarding sexual potency.
Disciplines :
Urology & nephrology
Author, co-author :
Bonnet, Pierre ; Centre Hospitalier Universitaire de Liège - CHU > Urologie
Coppens, Luc ; Centre Hospitalier Universitaire de Liège - CHU > Urologie
Andrianne, Robert ; Université de Liège - ULiège > Département des sciences cliniques > Département des sciences cliniques
Waltregny, David ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Labo de recherche sur les métastases
Keppenne, Véronique ; Centre Hospitalier Universitaire de Liège - CHU > Urologie
Leduc, F.
Fillet, Marc ; Centre Hospitalier Universitaire de Liège - CHU > Urologie
Ghammad, Saad
de Leval, Jean ; Université de Liège - ULiège > Département des sciences cliniques > Urologie
Language :
French
Title :
Chirurgie, radiotherapie ou hormonotherapie dans le traitement du cancer de la prostate
Alternative titles :
[en] surgery, Radiotherapy or Hormonal Therapy in the Treatment of Prostate Cancer
Publication date :
November 1999
Journal title :
Revue Médicale de Liège
ISSN :
0370-629X
eISSN :
2566-1566
Publisher :
Université de Liège. Revue Médicale de Liège, Liège, Belgium
